MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Focal Segmental Glomerulosclerosis

  1. Home
  2. Diseases
  3. Focal Segmental Glomerulosclerosis
  4. Clinical Trials

Clinical Trials Related to Focal Segmental Glomerulosclerosis

Related studies linked through entity extraction aliases.

NCT07268638

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Status
RECRUITING
Phase
PHASE2

NCT07220083

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Status
RECRUITING
Phase
PHASE3

NCT06664814

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

Status
RECRUITING
Phase
PHASE2

NCT06500702

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Status
RECRUITING
Phase
PHASE2

NCT05650619

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Status
RECRUITING
Phase
N/A

NCT05003986

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Status
RECRUITING
Phase
PHASE2

NCT04571658

NEPTUNE Match Study

Status
RECRUITING
Phase
NA

NCT00001393

Genetic Markers for Focal Segmental Glomerulosclerosis

Status
COMPLETED
Phase
N/A

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.